This review describes the recent Food and Drug Administration (FDA)-approved drugs (in
the year 2021) containing at least one halogen atom (covalently bound). The structures …

Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous
system characterized by inflammatory demyelination and axonal/neuronal damage. The …

Background: Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative
disease. Over time, symptoms accumulate leading to increased disability of patients …

Multiple sclerosis (MS) is the most famous autoimmune disease attacking the central
nervous system. It attacks people from age 20–50 years old and the females' attacks double …

Introduction: To estimate the value of interventions in multiple sclerosis (MS)–where lifetime
costs and outcomes cannot be observed–outcome data have to be combined with costs …

Background: Mobile health (mHealth) apps might have the potential to promote self-
management of people with multiple sclerosis (MS) in everyday life. However, the uptake of …

Introduction: Worldwide, incidence and prevalence of multiple sclerosis (MS) have
increased over the last decades. We present a systematic epidemiological study with recent …

Objective To assess clinical characteristics, distribution of disease-modifying treatments
(DMTs), and neuropsychological symptoms in a large cohort of patients with early-stage MS …

Objectives Studies on the east‐west gradient of multiple sclerosis (MS) are scarce. In
Finland, epidemiological differences have been only partially elucidated, but the MS risk is …

Background Multiple Sclerosis (MS) is a chronic inflammatory, immune mediated disease of
the central nervous system, with Relapsing Remitting MS (RRMS) being the most common …